Tilray Brands (TLRY) Non-Current Deferred Tax Liability (2018 - 2026)

Tilray Brands (TLRY) posted Non-Current Deferred Tax Liability of $7.9 million for Q1 2026, up 40.11% on a QoQ basis from $5.6 million in Q4 2025.

Tilray Brands (TLRY) Non-Current Deferred Tax Liability (2018 - 2026) Analysis & Trends

Tilray Brands' Non-Current Deferred Tax Liability history runs 9 years deep, the most recent figure standing at $7.9 million for Q1 2026.

  • Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $7.9 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $7.9 million (changed N/A YoY) and the FY2025 annual result came in at $3.7 million, down 98.47% from the prior year.
  • Non-Current Deferred Tax Liability was $7.9 million for Q1 2026 at Tilray Brands, up from $5.6 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $244.5 million in Q2 2024 and bottomed at $1.9 million in Q3 2025.
  • A 5-year average of $134.8 million and a median of $165.4 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
  • Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability soared 46.09% — and 2025, when it plunged 98.57%.
  • Tilray Brands' Non-Current Deferred Tax Liability stood at $180.1 million in 2022, then dropped by 7.58% to $166.5 million in 2023, then declined by 24.32% to $126.0 million in 2024, then tumbled by 95.54% to $5.6 million in 2025, then soared by 40.11% to $7.9 million in 2026.
  • Business Quant data shows TLRY's Non-Current Deferred Tax Liability at $7.9 million in Q1 2026, $5.6 million in Q4 2025, and $1.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Tilray Brands 465.02 Mn 373.06 Mn 54.95 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 7.88 Mn
Feb 28, 2026 7.88 Mn
Nov 30, 2025 5.62 Mn
Nov 30, 2025 5.62 Mn
Aug 31, 2025 1.94 Mn
Aug 31, 2025 1.94 Mn
May 31, 2025 3.75 Mn
May 31, 2025 3.75 Mn
Nov 30, 2024 125.98 Mn
Nov 30, 2024 125.98 Mn
Aug 31, 2024 136.23 Mn
Aug 31, 2024 136.23 Mn
May 31, 2024 244.50 Mn
May 31, 2024 244.50 Mn
Feb 29, 2024 161.04 Mn
Feb 29, 2024 161.04 Mn
Nov 30, 2023 166.45 Mn
Nov 30, 2023 166.45 Mn
Aug 31, 2023 169.63 Mn
Aug 31, 2023 169.63 Mn